Sonnet BioTherapeutics

1 follower

‌

Sonnet’s proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms.

Industries

Biotechnology

Headquarters

Princeton, United States

Employees

11-50

Links

Org chart

Pankaj Mohan

Founder, CEO & Chairman

Pankaj Mohan

Collapse

John K. Cini

Chief Scientific Officer & Co Founder

Jay Cross

CFO

Susan Dexter

Chief Technical Officer

Richard Kenney

Chief Medical Officer

Stephen J. McAndrew

Vice President, Business Development

Kal Ghosh

Executive Administrative Assistant

Teams

Directors

5 members

Leadership Team

5 members

Advisory Team

4 members

Similar companies

Immunome

2 followers

BeiGene

19 followers

Tessera Therapeutics

2 followers

Ventyx Biosciences

1 follower

Pyxis Oncology

1 follower

Mineralys Therapeutics

1 follower

Thrive Capital

26 followers

aescape

6 followers

StorONE

6 followers

Render

5 followers

FlyQuest

1 follower

Explore companies